20(S)-Ginsenoside Rg3 T3402
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ginsenoside Rg3 possess an ability to inhibit the lung metastasis of tumor cells via inhibition of the adhesion and invasion of tumor cells. It inhibits the proliferation of human umbilical vein endothelial cells(HUVEC) and has anti-angiogenesis activitie
CAS nr:
14197-60-5
Purity:
98%
Molecular Weight:
785,02
SMILES:
C\C(C)=C/CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C
Formula:
C42H72O13
Pathway:
Metabolism,NF-_b,Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling,Neuroscience,Immunology/Inflammation,Membrane transporter/Ion channel,Neuroscience,Membrane transporter/Ion channel
Target:
Endogenous Metabolite,NF-_B,EGFR,EGFR,EGFR,COX,COX,Sodium Channel,Beta Amyloid,Potassium Channel
